Otenabant
From Infogalactic: the planetary knowledge core
File:Otenabant.svg | |
Systematic (IUPAC) name | |
---|---|
1-[8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl]-4-(ethylamino)piperidine-4- carboxamide
|
|
Identifiers | |
CAS Number | 686344-29-6 |
ATC code | none |
PubChem | CID: 10052040 |
ChemSpider | 8227602 |
UNII | J8211Y53EF |
KEGG | D09362 |
ChEMBL | CHEMBL562668 |
Chemical data | |
Formula | C25H25Cl2N7O |
Molecular mass | 510.4 g/mol |
|
|
|
|
(what is this?) (verify) |
Otenabant (CP-945,598) is a drug which acts as a potent and highly selective CB1 antagonist.[1] It was developed by Pfizer for the treatment of obesity,[2] but development for this application has been discontinued following the problems seen during clinical use of the similar drug rimonabant.[3]
See also
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Woods SC. The endocannabinoid system: novel pathway for cardiometabolic Risk-factor reduction. Journal of the American Academy of Physician Assistants. 2007 Nov;Suppl Endocannabinoid:7-10. PMID 18047036
- ↑ http://www.pfizer.com
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Articles with changed InChI identifier
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Drugs not assigned an ATC code
- Drugs with no legal status
- Cannabinoids
- Purines
- Piperidines
- Carboxamides
- Chloroarenes
- Pfizer
- CB1 receptor antagonists
- Cannabinoid stubs